Form 4 for SLDE Slide Insurance Holdings, Inc.
Accepted 2026-01-05 00:00:00 ET · period of report 2025-12-31 · accession 0001193125-26-002525 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-05 | 2025-12-31 | SLDE | Lucas Shannon | Pres, COO, Dir, 10% | M - OptEx | $0.00 | +22.9K | 275.0K | +9% | $0 |
| DM | 2026-01-05 | 2025-12-31 | SLDE | Lucas Shannon | Pres, COO, Dir, 10% | F - Tax | $14.60 | -108.2K | 211.9K | -34% | -$1.58M |
| DI | 2026-01-05 | 2025-12-31 | SLDE | Lucas Shannon | Pres, COO, Dir, 10% | M - OptEx | $0.00 | +22.9K | 1.10M | +2% | $0 |
| DI | 2026-01-05 | 2025-12-31 | SLDE | Lucas Shannon | Pres, COO, Dir, 10% | M - OptEx | $0.00 | -22.9K | 277.0K | -8% | $0 |
| D | 2026-01-05 | 2025-12-31 | SLDE | Lucas Shannon | Pres, COO, Dir, 10% | M - OptEx | $0.00 | -22.9K | 277.0K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-31 | M | A | 22,918 | $0.00 | 275,018 | D By Spouse | — | — | (F5) Represent shares of common stock beneficially owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| 2 | Common | Common Stock | 2025-12-31 | F | D | 45,095 | $10.64 | 229,923 | D | — | — | (F2) The reported shares were withheld to cover the reporting person's tax liability associated with the restricted stock units that vested during 2025. (F3) The price shown reflects a 409(A) valuation of the common stock prior to the Issuer's initial public offering which was used to calculate the tax liability for all restricted stock units that vested prior to the Issuer's initial public offering. |
| 3 | Common | Common Stock | 2025-12-31 | F | D | 9,019 | $21.66 | 220,904 | D | — | — | (F2) The reported shares were withheld to cover the reporting person's tax liability associated with the restricted stock units that vested during 2025. (F4) The price shown is the closing price for the issuer's common stock on the NYSE on the day immediately prior to the respective vesting date. |
| 4 | Common | Common Stock | 2025-12-31 | M | A | 22,918 | $0.00 | 1,096,180 | I | — | — | (F6) The amount shown reflects the amount owned by the reporting person's spouse after the withholding of 108,228 shares of common stock for the payment of the tax liability associated with the vesting of restricted stock units throughout 2025. |
| 5 | Common | Common Stock | 2025-12-31 | F | D | 9,019 | $19.55 | 166,790 | D | — | — | (F2) The reported shares were withheld to cover the reporting person's tax liability associated with the restricted stock units that vested during 2025. (F4) The price shown is the closing price for the issuer's common stock on the NYSE on the day immediately prior to the respective vesting date. |
| 6 | Common | Common Stock | 2025-12-31 | F | D | 9,019 | $16.89 | 175,809 | D | — | — | (F2) The reported shares were withheld to cover the reporting person's tax liability associated with the restricted stock units that vested during 2025. (F4) The price shown is the closing price for the issuer's common stock on the NYSE on the day immediately prior to the respective vesting date. |
| 7 | Common | Common Stock | 2025-12-31 | F | D | 9,019 | $15.99 | 184,828 | D | — | — | (F2) The reported shares were withheld to cover the reporting person's tax liability associated with the restricted stock units that vested during 2025. (F4) The price shown is the closing price for the issuer's common stock on the NYSE on the day immediately prior to the respective vesting date. |
| 8 | Common | Common Stock | 2025-12-31 | F | D | 9,019 | $15.79 | 193,847 | D | — | — | (F2) The reported shares were withheld to cover the reporting person's tax liability associated with the restricted stock units that vested during 2025. (F4) The price shown is the closing price for the issuer's common stock on the NYSE on the day immediately prior to the respective vesting date. |
| 9 | Common | Common Stock | 2025-12-31 | F | D | 9,019 | $13.38 | 202,866 | D | — | — | (F2) The reported shares were withheld to cover the reporting person's tax liability associated with the restricted stock units that vested during 2025. (F4) The price shown is the closing price for the issuer's common stock on the NYSE on the day immediately prior to the respective vesting date. |
| 10 | Common | Common Stock | 2025-12-31 | F | D | 9,019 | $18.80 | 211,885 | D | — | — | (F2) The reported shares were withheld to cover the reporting person's tax liability associated with the restricted stock units that vested during 2025. (F4) The price shown is the closing price for the issuer's common stock on the NYSE on the day immediately prior to the respective vesting date. |
| 11 | Derivative | Restricted Stock Unit | 2025-12-31 | M | D | 22,918 | $0.00 | 276,981 | I | — · — to — | 22,918 Common Stock | (F12) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. (F13) These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the reporting person's continued employment or service through each applicable vesting date. |
| 12 | Derivative | Restricted Stock Unit | 2025-12-31 | M | D | 22,918 | $0.00 | 276,981 | D By Spouse | — · — to — | 22,918 Common Stock | (F5) Represent shares of common stock beneficially owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. (F12) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. (F13) These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the reporting person's continued employment or service through each applicable vesting date. |